Jake Simson's Insider Trades & SAST Disclosures
Jake Simson's most recent trade in Bicara Therapeutics Inc. was a trade of 23,746 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jake Simson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 23,746 | 23,746 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 2,500 | - | 0 | Common Stock | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 18,600 | 18,600 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges